BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12538702)

  • 1. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
    Fitzgerald JC; Gao GP; Reyes-Sandoval A; Pavlakis GN; Xiang ZQ; Wlazlo AP; Giles-Davis W; Wilson JM; Ertl HC
    J Immunol; 2003 Feb; 170(3):1416-22. PubMed ID: 12538702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.
    Pinto AR; Fitzgerald JC; Giles-Davis W; Gao GP; Wilson JM; Ertl HC
    J Immunol; 2003 Dec; 171(12):6774-9. PubMed ID: 14662882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector.
    Pinto AR; Fitzgerald JC; Gao GP; Wilson JM; Ertl HC
    Vaccine; 2004 Jan; 22(5-6):697-703. PubMed ID: 14741162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus.
    de Souza AP; Haut LH; Silva R; Ferreira SI; Zanetti CR; Ertl HC; Pinto AR
    Vaccine; 2007 Jan; 25(1):109-16. PubMed ID: 16914235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice.
    Xiang Z; Li Y; Gao G; Wilson JM; Ertl HC
    J Immunol; 2003 Oct; 171(8):4287-93. PubMed ID: 14530353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
    Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
    Front Immunol; 2018; 9():335. PubMed ID: 29563911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
    Peters C; Peng X; Douven D; Pan ZK; Paterson Y
    J Immunol; 2003 May; 170(10):5176-87. PubMed ID: 12734365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an adenoviral vaccine vector based on simian adenovirus 21.
    Roy S; Zhi Y; Kobinger GP; Figueredo J; Calcedo R; Miller JR; Feldmann H; Wilson JM
    J Gen Virol; 2006 Sep; 87(Pt 9):2477-2485. PubMed ID: 16894185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
    Barouch DH; Pau MG; Custers JH; Koudstaal W; Kostense S; Havenga MJ; Truitt DM; Sumida SM; Kishko MG; Arthur JC; Korioth-Schmitz B; Newberg MH; Gorgone DA; Lifton MA; Panicali DL; Nabel GJ; Letvin NL; Goudsmit J
    J Immunol; 2004 May; 172(10):6290-7. PubMed ID: 15128818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimpanzee-origin adenovirus vectors as vaccine carriers.
    Tatsis N; Tesema L; Robinson ER; Giles-Davis W; McCoy K; Gao GP; Wilson JM; Ertl HC
    Gene Ther; 2006 Mar; 13(5):421-9. PubMed ID: 16319951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.
    Tritel M; Stoddard AM; Flynn BJ; Darrah PA; Wu CY; Wille U; Shah JA; Huang Y; Xu L; Betts MR; Nabel GJ; Seder RA
    J Immunol; 2003 Sep; 171(5):2538-47. PubMed ID: 12928404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5- and 35-based vectors.
    Barratt-Boyes SM; Soloff AC; Gao W; Nwanegbo E; Liu X; Rajakumar PA; Brown KN; Robbins PD; Murphey-Corb M; Day RD; Gambotto A
    J Gen Virol; 2006 Jan; 87(Pt 1):139-149. PubMed ID: 16361426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.
    Quinn KM; Da Costa A; Yamamoto A; Berry D; Lindsay RW; Darrah PA; Wang L; Cheng C; Kong WP; Gall JG; Nicosia A; Folgori A; Colloca S; Cortese R; Gostick E; Price DA; Gomez CE; Esteban M; Wyatt LS; Moss B; Morgan C; Roederer M; Bailer RT; Nabel GJ; Koup RA; Seder RA
    J Immunol; 2013 Mar; 190(6):2720-35. PubMed ID: 23390298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes.
    Reyes-Sandoval A; Fitzgerald JC; Grant R; Roy S; Xiang ZQ; Li Y; Gao GP; Wilson JM; Ertl HC
    J Virol; 2004 Jul; 78(14):7392-9. PubMed ID: 15220412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees.
    Natuk RJ; Lubeck MD; Chanda PK; Chengalvala M; Wade MS; Murthy SC; Wilhelm J; Vernon SK; Dheer SK; Mizutani S
    AIDS Res Hum Retroviruses; 1993 May; 9(5):395-404. PubMed ID: 8318268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gag.
    Haut LH; Lin SW; Tatsis N; DiMenna LJ; Giles-Davis W; Pinto AR; Ertl HC
    Eur J Immunol; 2010 Dec; 40(12):3426-38. PubMed ID: 21108465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ; Yang Y; Wilson JM; Ertl HC
    Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
    Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
    J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
    Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
    J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.